Korean J Obstet Gynecol.  2006 May;49(5):1060-1064.

Clusterin expression and paclitaxel resistance in cervical cancer cell lines

Affiliations
  • 1Department of Obstetrics and Gynecology, The Catholic University of Korea. dcpark@catholic.ac.kr
  • 2Research Institute of Medical Science of Saint Vincent Hospital, The Catholic University of Korea.

Abstract


OBJECTIVE
The purpose of this study was to evaluate whether clusterin expression is significantly correlated with paclitaxel resistance in cervical cancer cell lines.
METHODS
The expressions of clusterin in cervical cancer cell lines were validated with western blotting. And subsequently, the correlation between clusterin expression levels and the IC50 of paclitaxel in several cervical cancer cell lines was evaluated. After transfection of clusterin siRNA into HeLaS3, which expressed high level of clusterin, their effect on chemo-resistance was evaluated by XTT assay.
RESULTS
Clusterin expression levels were correlated with paclitaxel resistance in cervical cancer cell lines. And after transfection of clusterin siRNA into HeLa-S3 significantly decreased paclitaxel resistance (P<0.05).
CONCLUSION
These findings suggest that clusterin expression may correlate with paclitaxel resistance.

Keyword

Clusterin; Cervical cancer; Paclitaxel; Drug resistance

MeSH Terms

Blotting, Western
Cell Line*
Clusterin*
Drug Resistance
Inhibitory Concentration 50
Paclitaxel*
RNA, Small Interfering
Transfection
Uterine Cervical Neoplasms*
Clusterin
Paclitaxel
RNA, Small Interfering
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr